|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/05 | (2006.01) |
| A61K 36/185 | (2013.01) | ||
| A61K 36/185 | (2006.01) | ||
| A61K 31/05 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 25/08 | (2018.01) | ||
| A61P 25/08 | (2006.01) | ||
| A61K 45/06 | (2013.01) |
| (11) | Number of the document | 3888641 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21166413.1 |
| Date of filing the European patent application | 2015-10-14 | |
| (97) | Date of publication of the European application | 2021-10-06 |
| (45) | Date of publication and mention of the grant of the patent | 2025-09-10 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201418169 | 2014-10-14 | GB |
| (72) |
GUY, Geoffrey , GB
WRIGHT, Stephen , GB
MEAD, Alice , GB
DEVINSKY, Orrin , US
|
| (73) |
Jazz Pharmaceuticals Research UK Limited ,
Building 730 Kent Science Park, Sittingbourne Kent ME9 8AG,
GB
|
| (54) | USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH DOOSE SYNDROME |
| USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH DOOSE SYNDROME |